Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
Authors:
Open Access
- 17 March 2017
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 19 (4) , 1-9
Abstract
Purpose of Review Cardiac troponin (cTn) plays an essential role for assessment of outcome in acute coronary syndrome (ACS). However, the prognostic value of cTn is not absolute. In this mini-review, we summarize the evidence on the utility of established biomarkers of left-ventricular dysfunction, hemodynamic stress, inflammation, and renal dysfunction for risk prediction beyond cTn in ACS. Recent Findings Only few biomarkers consistently demonstrate additive prognostic value to cTn levels. The B-type natriuretic peptides (NPs) and growth-differentiation factor-15 (GDF-15) are most promising in this regard. However, there are uncertainties regarding the role of these biomarkers for guidance of treatment decisions, and their prognostic increment to cTn levels measured with high-sensitivity assays is largely unknown. Summary The NPs and GDF-15 provide the strongest prognostic increment to cTn levels in ACS. However, the role of these biomarkers for clinical decision-making in contemporary settings has still to be defined.Keywords
Funding Information
- Uppsala University
This publication has 82 references indexed in Scilit:
- Cystatin C– and Creatinine-Based Estimates of Renal Function and Their Value for Risk Prediction in Patients with Acute Coronary Syndrome: Results from the PLATelet Inhibition and Patient Outcomes (PLATO) StudyClinical Chemistry, 2013
- Pre-discharge risk stratification in unselected STEMI: Is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?International Journal of Cardiology, 2013
- The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1Cytokine & Growth Factor Reviews, 2013
- Secreted proteins as a fundamental source for biomarker discoveryProteomics, 2012
- OverviewCirculation Research, 2011
- Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 TrialEuropean Heart Journal, 2010
- C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial InfarctionJournal of Cardiac Failure, 2008
- Plasma Natriuretic Peptides up to 2 Years After Acute Myocardial Infarction and Relation to Prognosis: An OPTIMAAL SubstudyJournal of Cardiac Failure, 2005
- Cardiac troponins in renal insufficiencyJACC, 2002
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976